Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |